C-reactive protein-triglyceride-glucose index versus triglyceride-glucose index in predicting cardiovascular metabolic multimorbidity risk: A cohort study
PLOS One · 06.02.2026 · 21 (2) · e0340098
DOI: 10.1371/journal.pone.0340098 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift PLOS One, online erschienen am 06.02.2026. Verfasst von Hongjin Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardio-Thoracic Surgery, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China. Hauptthemen laut MEDLINE: C-Reactive Protein, Triglycerides, Blood Glucose, Cardiovascular Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cardiovascular Metabolic Multimorbidity (CMM), a leading global cause of mortality, lacks evidence on the predictive utility of the novel C-reactive protein-triglyceride-glucose index (CTI), which integrates insulin resistance and inflammation. This study compared CTI with the established Triglyceride-Glucose (TyG) index in predicting CMM risk.
Methods
A cohort of 8,487 adults aged ≥45 from the CHARLS database (2011–2020) was analyzed. Over nine years, CMM events were tracked. Cox regression, restricted cubic spline (RCS), and ROC curve analyses assessed associations between TyG, CTI, and CMM risk. Subgroup analyses evaluated population-specific variations.
Results
Among participants, 1,030 (12.14%) developed CMM. Unadjusted Cox models showed TyG (HR = 1.89, 95%CI 1.73–2.07, P < 0.001) and CTI (HR = 1.83, 95%CI 1.70–1.97, P < 0.001) predicted CMM; adjusted models confirmed persistence. A dose–response association was observed for both CTI and TyG with CMM risk. In fully adjusted models, the overall dose–response trend remained similar. ROC analysis favored CTI (higher AUC). Subgroup analyses indicated TyG’s association varied by sex, smoking, and hypertension ( P < 0.05), while CTI’s association differed by age, sex, and hypertension ( P < 0.05).
Conclusions
Elevated CTI independently correlates with increased CMM risk, demonstrating superior predictive accuracy over TyG. Its linear association highlights potential clinical utility for early CMM risk stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardio-Thoracic Surgery, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
- First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
- Fujian Medical University, Fuzhou, China.
- Department of Gastroenterology and Anorectal Surgery, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
- Fuzhou University Affiliated Provincial Hospital, Fuzhou, China.
ORCID-Profile: Hongjin Wang
Zitieren
APA
Wang, H., Yang, M., Cai, W., Zeng, H., Luo, X., Xu, Z., Wu, J., Lin, Y., & Wang, Z. (2026). C-reactive protein-triglyceride-glucose index versus triglyceride-glucose index in predicting cardiovascular metabolic multimorbidity risk: A cohort study. PLOS One, 21(2), e0340098. https://doi.org/10.1371/journal.pone.0340098
Vancouver
Wang H, Yang M, Cai W, Zeng H, Luo X, Xu Z, et al. C-reactive protein-triglyceride-glucose index versus triglyceride-glucose index in predicting cardiovascular metabolic multimorbidity risk: A cohort study. PLOS One. 2026;21(2):e0340098. doi:10.1371/journal.pone.0340098
BibTeX
@article{Wang2026,
author = {Wang, Hongjin and Yang, Ming and Cai, Wenjing and Zeng, Hao and Luo, Xin and Xu, Zengkai and Wu, Jiahuang and Lin, Youdong and Wang, Zhisheng},
title = {C-reactive protein-triglyceride-glucose index versus triglyceride-glucose index in predicting cardiovascular metabolic multimorbidity risk: A cohort study},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {2},
pages = {e0340098},
doi = {10.1371/journal.pone.0340098}
}
EUVIMED